News

Event: Cancer Think Tank

Cure First is hosting the forum “Cancer Think Tank.” Speakers include ISB’s Dr. Ilya Shmulevich and Dr. Brady Bernard.

Date: January 21, 2016
Time: 1-5:30 p.m. MED talks, breakout sessions, and panel discussion; 6-8 p.m. networking with wine and dinner
Why: To jump start innovative collaborations in cancer research with the goal to submit proposals for funding to accelerate the discovery of new, less toxic and targeted therapies.
Who: This event is for you if you are a practicing specialist and interested in any of the following specialties: clinical oncology, computational sciences, patient advocacy, pharmaceutical R&D, cancer research, and genetics.
Where: Kakao, 415 Westlake Ave N, Seattle, WA 98109
Speakers: list

Cure First is bringing together from a variety of disciplines including research, clinical, computational science, pharmaceutical science, healthcare investment, to share their work and vision about the realities of what precision medicine can bring to cancer patients. With new high throughput screening (HTS) capabilities, we can now test hundreds of genes and target those that are cancer specific for more effective, less toxic therapies. Cancer Think Tank will provide a forum for experts to consider these and other approaches to identify new possibilities and further our understanding of how to kill cancer.

Agenda: New ideas and insights into potentially disruptive science and technology will b e shared through MED Talk presentations. In small working groups, facilitators will ask for ideas and examples of what can be done to develop new approaches for treating cancer. Research themes will surface from group interactions and be shared with the larger group for further investigation. From this exchange of ideas, topics for grants will be identified and sent out after the event to Cancer Think Tank participants for review. The afternoon will close with social networking, dinner and drinks.

Results: Funding for specific initiatives emerging from the conference will be pursued in the months following. Participants interested in working with other specialists will be invited to write segments of grant applications using a structured approach for faster development and strategic submission to funding institutions such as the NIH and NCI.

REGISTER

 

Recent Articles

  • Shmulevich-Thorsson

    ISB Researchers Among Recipients of AACR Team Science Award

    The American Association for Cancer Research (AACR) has recognized The Cancer Genome Atlas (TCGA) project with the 2020 AACR Team Science Awards. Award recipients include Dr. Ilya Shmulevich, ISB professor and head of the Shmulevich Lab; ISB senior research scientist Dr. Vésteinn Þórsson; and former Shmulevich Lab members Drs. Brady Bernard and Theo Knijnenburg.

  • ISB researchers

    Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

    ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

  • Spotlight on Caroline Cannistra, ISB Systems Research Scholar

    Caroline Cannistra joined ISB in 2018 as a Systems Research Scholar. The Systems Research Scholars Program provides recent college undergraduates a springboard to become the next generation’s pioneers of interdisciplinary scientific research.